Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP was delisted on the 7th of March, 2019.
80 hedge funds and large institutions have $142M invested in Synergy Pharmaceuticals, Inc Common Stock in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 35 reducing their positions, and 6 closing their positions.
133% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 6
119% more call options, than puts
Call options by funds: $1.55M | Put options by funds: $709K
11% more funds holding
Funds holding: 72 → 80 (+8)
2% more capital invested
Capital invested by funds: $139M → $142M (+$3.05M)
11% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$11.4M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.12M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.56M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$861K |
| 5 |
ProShare Advisors
Bethesda,
Maryland
|
+$585K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$4.97M |
| 2 |
B
Bailard
Foster City,
California
|
-$1.29M |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$850K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$634K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$414K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CA
76
CapWealth Advisors
Franklin,
Tennessee
| $11K | -$157 | -28 | -1% |
|
77
US Bancorp
Minneapolis,
Minnesota
| $6K | +$5.59K | +997 | +545% |
|
78
BNP Paribas Financial Markets
Paris,
France
| $2.56K | -$5.12K | -914 | -62% |
|
79
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $2K | +$1.79K | +320 | New |
|
80
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $331 | -$10.9K | -1,953 | -3% |
|
|
WAM
81
Wolverine Asset Management
Chicago,
Illinois
| – | -$850K | -153,211 | Closed |
|
|
TAM
82
Telluride Asset Management
Wayzata,
Minnesota
| – | -$374K | -67,288 | Closed |
|
|
SCA
83
Secor Capital Advisors
New York
| – | -$227K | -40,894 | Closed |
|
|
SCM
84
Stevens Capital Management
Radnor,
Pennsylvania
| – | -$159K | -28,661 | Closed |
|
|
AL
85
Airain Ltd
St. Peter Port,
Guernsey
| – | -$74K | -13,258 | Closed |
|
86
California Public Employees Retirement System
Sacramento,
California
| – | -$47K | -9,121 | Closed |
|
SGYP Hedge Fund Activity: Q1 2014 in Review
80 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) for Q1 2014, worth a combined $142M — up 2.2% from $139M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new SGYP positions and 6 closed out — a net gain of 8 holders — while 31 added to existing stakes and 35 trimmed.
The largest buyer was State Street, adding an estimated $11.4M. The largest seller was Baker Bros. Advisors, cutting an estimated $4.97M.
- 80 institutional investors held Synergy Pharmaceuticals, Inc Common Stock (SGYP) as of Q1 2014, up from 72 in Q4 2013.
- Funds reported $142M of Synergy Pharmaceuticals, Inc Common Stock stock for Q1 2014, up 2.2% quarter-over-quarter.
- 14 funds opened new Synergy Pharmaceuticals, Inc Common Stock positions in Q1 2014 and 6 closed out, a net change of +8 holders.
- The largest Synergy Pharmaceuticals, Inc Common Stock buyer in Q1 2014 was State Street, an estimated $11.4M added.
- The largest Synergy Pharmaceuticals, Inc Common Stock seller in Q1 2014 was Baker Bros. Advisors, an estimated $4.97M sold.
Based on aggregated 13F filings for Q1 2014.